Matches in Wikidata for { <http://www.wikidata.org/entity/Q90675421> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q90675421 description "article scientifique publié en 2019" @default.
- Q90675421 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q90675421 description "scientific article published on 07 January 2019" @default.
- Q90675421 description "wetenschappelijk artikel" @default.
- Q90675421 description "наукова стаття, опублікована 7 січня 2019" @default.
- Q90675421 name "Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia" @default.
- Q90675421 name "Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia" @default.
- Q90675421 type Item @default.
- Q90675421 label "Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia" @default.
- Q90675421 label "Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia" @default.
- Q90675421 prefLabel "Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia" @default.
- Q90675421 prefLabel "Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia" @default.
- Q90675421 P1433 Q90675421-14F0F8DE-2AE6-4CF8-B3C8-906C85D1C583 @default.
- Q90675421 P1476 Q90675421-04E4A9C9-27FB-4B2E-A1D3-7B07F922BB28 @default.
- Q90675421 P2093 Q90675421-081C5D58-FB0C-4CFF-9D62-D89808D62251 @default.
- Q90675421 P2093 Q90675421-E4D25249-FE57-4419-9F62-2C39A3BAB676 @default.
- Q90675421 P304 Q90675421-B054FE19-98C2-4244-BD15-1451F839F19D @default.
- Q90675421 P31 Q90675421-AFBC3F5B-1C5C-48D6-B9A0-4BAA769F47D0 @default.
- Q90675421 P356 Q90675421-3122D627-B7EE-4FCC-A0DF-18045743A9AF @default.
- Q90675421 P433 Q90675421-C6029FC0-34EB-4DAB-AD12-BA62FA35B54E @default.
- Q90675421 P478 Q90675421-4DD1E068-6C5A-48EF-A456-8F83ECB6FA86 @default.
- Q90675421 P577 Q90675421-C0F34A63-1427-497B-94F5-EC71F3ABDD8C @default.
- Q90675421 P698 Q90675421-35A72682-1666-4864-A51F-B377B5518478 @default.
- Q90675421 P921 Q90675421-07F321D1-40DA-493A-B2FF-280FD4ADF48E @default.
- Q90675421 P921 Q90675421-4CBE5CA5-F510-4091-9C41-7D1925B597F4 @default.
- Q90675421 P921 Q90675421-D5F0CE29-BEB3-401B-8968-2CD82A438A50 @default.
- Q90675421 P356 17474086.2019.1562332 @default.
- Q90675421 P698 30572725 @default.
- Q90675421 P1433 Q15734429 @default.
- Q90675421 P1476 "Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia" @default.
- Q90675421 P2093 "Massimo Breccia" @default.
- Q90675421 P2093 "Robin Foà" @default.
- Q90675421 P304 "81-87" @default.
- Q90675421 P31 Q13442814 @default.
- Q90675421 P356 "10.1080/17474086.2019.1562332" @default.
- Q90675421 P433 "2" @default.
- Q90675421 P478 "12" @default.
- Q90675421 P577 "2019-01-07T00:00:00Z" @default.
- Q90675421 P698 "30572725" @default.
- Q90675421 P921 Q29417 @default.
- Q90675421 P921 Q612108 @default.
- Q90675421 P921 Q7739 @default.